Authors
Luc Buée, Kristin R Wildsmith, Suvarna Alladi, Taylor Bertucci, Delphine Boche, Kathryn R Bowles, Adam Boxer, Jennifer Brummet, Sarah L DeVos, Kristophe Diaz, Anna Jane Dreyer, Karen Duff, Claudia Duran-Aniotz, Claire S Durrant, Kurt Farrell, Igor C Fontana, Nicolai Franzmeier, Bess Frost, Kanta Horie, Petr Kaňovský, Aimee W Kao, Simin Mahinrad, Maura Malpetti, Huw R Morris, Carla Palleis, Leonard Petrucelli, Jessica Rexach, Larisa Reyderman, Amy Rommel, James B Rowe, Sandra M Sanabria Bohórquez, Chihiro Sato, Michael Schöll, Anja Schneider, Rohan de Silva, Heather M Snyder, Lawren VandeVrede, Andrew W Varga, Jacob W Vogel, Felix L Yeh, Andrew S Yoo, Maria C Carrillo
Published in
Alzheimer's & dementia : the journal of the Alzheimer's Association. Volume 22. Issue 6. Pages e71431.
Abstract
The Tau Global Conference 2025, hosted by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation, convened international experts from academia, industry, government, and philanthropy to explore advances and challenges in tauopathy research. The meeting highlighted progress across tau biology, including emerging models of tau regulation, degradation, and propagation; advances in biomarker development for the diagnosis and staging of tauopathies; and evolving therapeutic strategies targeting diverse aspects of tau pathophysiology. Discussions also emphasized the importance of cross-sector collaboration, and global initiatives to address disparities in tau research. This report synthesizes key insights from the conference and underscores the critical role of interdisciplinary, biomarker-driven, and globally inclusive approaches in accelerating the translation of tau research into effective clinical applications.
PMID:
42324487
Bibliographic data and abstract were imported from PubMed on 22 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0